StockData
Ardelyx, Inc. logo

Ardelyx, Inc. (ARDX) stock

ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3058% below fair value
$3.18+0.11 (+3.58%)

Close on Nov 17, 2026Market cap $792.42MP/E –Yield –

Ardelyx price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Ardelyx's price to book ratio was 5.2× on Nov 11, 2026, against 9.1× a year earlier. Over the last 5 years it ranged from 1.1× to 13.0×, with a median of 7.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.2×−3.9
2025Dec 31, 20259.2×+1.6
2024Dec 31, 20247.6×+0.1
2023Dec 29, 20237.5×−0.5
2022Dec 30, 20228.0×+6.5
2021Dec 31, 20211.4×−3.0
2020Dec 31, 20204.4×−5.2
2019Dec 31, 20199.6×+8.8
2018Dec 31, 20180.8×−1.7
2017Dec 29, 20172.5×−0.5
2016Dec 30, 20163.0×−0.7
2015Dec 31, 20153.8×−1.7
2014Dec 31, 20145.5×–

More Ardelyx figures

See a number that looks wrong?